Human tumor-associated kazal inhibitor
CA 2287779 A1 · Owner: Guegler, Karl J. · Inventors: Bandman, Olga; Guegler, Karl J.; Shah, Purvi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a human tumor-associated Kazal inhibitor (HuKI) and polynucleotides which identify and encode HuKI. The invention also provides expression vectors, host cells antibodies and antagonists. The , invention also provides methods for the prevention and treatment of diseases associated with expression of HuKI, as well as diagnostic assays.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 14, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 14, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 14, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.